Loracarbef versus cefaclor in the treatment of urinary tract infections in women.
In a double-blind, prospective, randomized study, 108 college women with acute urinary tract infections were treated for 7 days with either loracarbef (LY163892) at 200 mg once daily (n = 53) or cefaclor at 250 mg three times daily (n = 55). The cure rates at 5 to 9 days after treatment in the lorac...
Gespeichert in:
| Veröffentlicht in: | Antimicrob Agents Chemother |
|---|---|
| 1. Verfasser: | |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Microbiology (ASM)
1991
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC245091/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2069382/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.35.4.750 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|